We had the pleasure of interviewing Nick Kadysh of PharmAla Biotech Inc. at the Psychedelic Therapeutics & Drug Development Conference in New Orleans a few weeks ago. We discussed the pipeline status of MDMA analogs and the broader trajectory of the field. As he puts it, “the wave of clinical data coming to us is unparalleled in the history of neuropsychiatry.” This interview is part of the live conference coverage by Cascades Analytics, in partnership with Arrowhead SciTech Conferences & Events.